Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Fearon

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
BMJ Supportive & Palliative Care|February 15, 2018
Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trialTora S Solheim, Barry J A Laird, Trude R Balstad, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 15, 2017
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancerTora S Solheim, Barry J A Laird, Trude Rakel Balstad, et al.
The Lancet. Oncology|February 8, 2011
Definition and classification of cancer cachexia: an international consensusKenneth Fearon, Florian Strasser, Stefan D Anker, et al.
Scientific Reports|May 19, 2017
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signalingKristine Pettersen, Sonja Andersen, Simone Degen, et al.
Journal of the American Medical Directors Association|June 7, 2011
Sarcopenia with limited mobility: an international consensusJohn E Morley, Angela Marie Abbatecola, Josep M Argiles, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
BMJ Supportive & Palliative Care|February 15, 2018
Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trialTora S Solheim, Barry J A Laird, Trude R Balstad, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 15, 2017
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancerTora S Solheim, Barry J A Laird, Trude Rakel Balstad, et al.
The Lancet. Oncology|February 8, 2011
Definition and classification of cancer cachexia: an international consensusKenneth Fearon, Florian Strasser, Stefan D Anker, et al.
Scientific Reports|May 19, 2017
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signalingKristine Pettersen, Sonja Andersen, Simone Degen, et al.
Journal of the American Medical Directors Association|June 7, 2011
Sarcopenia with limited mobility: an international consensusJohn E Morley, Angela Marie Abbatecola, Josep M Argiles, et al.
Pageof 2